RetaZaktide David
11.2K posts

RetaZaktide David
@ZakDavid
Peptide Evangelist. https://t.co/8ffDAzgUly Data Science Advisor https://t.co/mnxQ07kexY


Friend got a marketing email from Medvi this morning. Email copy aside, the provider they are using in the screenshot is an actual doctor, not an NP, whose real name is Alec Wier, and he is COMPLETELY UNAFFILIATED with Medvi. This entire company is run on fraud and deception and I hope the founder ends up in prison

@hope_indecay @duncanthedev @PeptidePartners Nexaph (this is not an ad)



Trump just signed 100% tariffs on patented pharmaceuticals and their APIs (the raw ingredients used to make drugs) This basically means 2 things: 1. Big pharma that cut deals with the White House → 0% tariff. Fully protected 2. Compounding pharmacies making affordable personalized medicine → input costs spike overnight The irony here is that the FDA spent the last year cracking down on the compounders actually following the rules. Bad actors kept operating anyway. Now tariffs punish the ones left playing by the rules whitehouse.gov/fact-sheets/20…


“The Curious Case of the L-Carnitine in the COA” up on the stack now [link below]


Ozempic looks like a miracle… until it isn’t. Bill Maher asked Jillian Michaels the question a lot of people are quietly wondering: if these weight-loss drugs are so great, why isn’t anyone talking about the downsides? Her answer was direct and data-heavy. About 50% of users feel great at first with no side effects. Then comes the inevitable plateau. Stopping the drug almost always leads to regaining most or all of the weight — often with a brutal rebound effect. She also highlighted more serious risks like stomach paralysis, intestinal blockage, pancreatitis, and kidney issues. Meanwhile, the weight-loss drug industry is growing at a 9% compound annual rate, and many doctors stay quiet because of grant money and industry influence. It’s a raw conversation that cuts through the hype. What do you think — is the Ozempic boom being oversold, or are the benefits worth the risks and lifelong commitment?



I'll be on CNN Smerconish show tomorrow sometime in 9:30- 9:45am ET, talking on prediction markets.



As someone who has covered cancer drug development for 25 years, one of the few things I am sure of is that the odds of technology folks thinking they understand biology are much higher than the odds they actually do.








